Headquartered in New York City, Noom is a leading behavioural change company, disrupting the weight loss and healthcare industries. By combining the power of AI, mobile technology and psychology with the empathy of more than 1,000 personal coaches, Noom helps people live healthier lives by changing their long-term habits. More than 50 million people have benefitted from Noom’s behavioural change courses, including its virtual diabetes prevention programme, which was the first of its kind to be recognized by the US Centers for Disease Control and Prevention (CDC). The Noom platform is used by leading healthcare and pharmaceutical companies to improve treatment outcomes for patients.
Collective action is needed to bring the health benefits of GLP-1 medications to more people, and key to that is a system of trust and equitable access.
While technology is a key contributor to improving health outcomes, over-reliance on it risks eroding human connections that are equally important.
